Michael Hummel

← Back to Freie Universität Berlin

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

1. The repertoire of mutational signatures in human cancer

   2020 · 3,468 citations

2. Pan-cancer analysis of whole genomes

   2020 · 3,054 citations

3. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

   2003 · 3,043 citations

4. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

   2020 · 1,456 citations

5. Senescence-associated reprogramming promotes cancer stemness

   2017 · 1,123 citations

6. The evolutionary history of 2,658 cancers

   2020 · 1,046 citations

7. A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

   2006 · 1,006 citations

8. Swarm Learning for decentralized and confidential clinical machine learning

   2021 · 879 citations

9. Patterns of somatic structural variation in human cancer genomes

   2020 · 866 citations

10. Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection

    1997 · 860 citations

11. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

    2020 · 713 citations

12. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

    2007 · 694 citations

13. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.

    1999 · 645 citations

14. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

    1992 · 643 citations

15. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

    2020 · 602 citations

16. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

    2013 · 542 citations

17. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy

    2013 · 541 citations

18. Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data

    1997 · 506 citations

19. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

    2012 · 500 citations

20. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription

    2000 · 499 citations

21. Comprehensive molecular characterization of mitochondrial genomes in human cancers

    2020 · 465 citations

22. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

    2020 · 449 citations

23. Lymphoproliferative lesions of the ocular adnexa

    1998 · 405 citations

24. Genomic basis for RNA alterations in cancer

    2020 · 393 citations

25. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.

    1991 · 383 citations

← Return to the university profile